DERM - CIK 0001867066
The table below shows Journey Medical Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $2.91M | -$2.83M | -$5.02M | -$956.00K | $884.00K | $1.36M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | - | - | - | -$5.00M | -$20.00M | - |
| Dividends paid | - | - | - | - | - | - |
Journey Medical Corp reported operating cash flow of -$12.44M for fiscal year 2025. That is down 36.3% from -$9.13M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from $5.13M (FY 2020) to -$12.44M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $220.00K | $3.60M | $1.64M | $52.00K | $11.37M | $9.39M |